USP22 promotes gefitinib resistance and inhibits ferroptosis in non‐small cell lung cancer by deubiquitination of MDM2
Abstract Background The emergence of chemoresistance markedly compromised the treatment efficiency of human cancer, including non‐small cell lung cancer (NSCLC). In the present study, we aimed to explore the effects of ubiquitin‐specific peptidase 22 (USP22) and murine double minute 2 (MDM2) in gefi...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2024-11-01
|
| סדרה: | Thoracic Cancer |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1111/1759-7714.15439 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
